The health consequences of cannabis use in developing countries are largely unknown beacuse of limited and non-systematic research, but there is no reason a priori to expect that biological effects on individuals in these populations would be substantially different to what has been observed in developed countries. However, other consequences might be different given the cultural and social differences between countries.
Scott Shannon, M.D., assistant clinical professor at the University of Colorado, recently sifted through patient charts from his four-doctor practice to document CBD’s effects on anxiety. His study, as yet unpublished, found “a fairly rapid decrease in anxiety scores that appears to persist for months,” he says. But he says he can’t discount a placebo effect, especially since “there’s a lot of hype right now.”
While researchers are calling for more robust studies on the role of CBD on mood disorders, there is promising research that points to CBD’s role as an anxiolytic – which means it has anti-anxiety effects. Another study showed CBD to have antidepressant effects comparable to those of the prescription antidepressant Imipramine. We noted above that CBD increases levels of glutamate and serotonin – and it’s these same neurotransmitters that play a crucial role in mood regulation.
Hemp plants can be vulnerable to various pathogens, including bacteria, fungi, nematodes, viruses and other miscellaneous pathogens. Such diseases often lead to reduced fiber quality, stunted growth, and death of the plant. These diseases rarely affect the yield of a hemp field, so hemp production is not traditionally dependent on the use of pesticides.
In 1937, the U.S. Treasury Department introduced the Marihuana Tax Act. This Act imposed a levy of $1 per ounce for medicinal use of Cannabis and $100 per ounce for nonmedical use. Physicians in the United States were the principal opponents of the Act. The American Medical Association (AMA) opposed the Act because physicians were required to pay a special tax for prescribing Cannabis, use special order forms to procure it, and keep special records concerning its professional use. In addition, the AMA believed that objective evidence that Cannabis was harmful was lacking and that passage of the Act would impede further research into its medicinal worth. In 1942, Cannabis was removed from the U.S. Pharmacopoeia because of persistent concerns about its potential to cause harm.[2,3]
Van Roekel (1994) has pointed out that Egyptian papyrus sheets are not “paper,” because the fiber strands are woven, not “wet-laid;” the oldest surviving paper is over 2,000 years of age, from China, and was made from hemp fiber (Fleming and Clarke 1998). Until the early 19th century, hemp, and flax were the chief paper-making materials. In historical times, hemp rag was processed into paper. Using hemp directly for paper was considered too expensive, and in any event the demand for paper was far more limited than today. Wood-based paper came into use when mechanical and chemical pulping was developed in the mid 1800s in Germany and England. Today, at least 95% of paper is made from wood pulp.
There have been ten clinical trials on the use of inhaled Cannabis in cancer patients that can be divided into two groups. In one group, four small studies assessed antiemetic activity but each explored a different patient population and chemotherapy regimen. One study demonstrated no effect, the second study showed a positive effect versus placebo, the report of the third study did not provide enough information to characterize the overall outcome as positive or neutral. Consequently, there are insufficient data to provide an overall level of evidence assessment for the use of Cannabis for chemotherapy-induced N/V. Apparently, there are no published controlled clinical trials on the use of inhaled Cannabis for other cancer-related or cancer treatment–related symptoms.
Reference citations in some PDQ cancer information summaries may include links to external websites that are operated by individuals or organizations for the purpose of marketing or advocating the use of specific treatments or products. These reference citations are included for informational purposes only. Their inclusion should not be viewed as an endorsement of the content of the websites, or of any treatment or product, by the PDQ Integrative, Alternative, and Complementary Therapies Editorial Board or the National Cancer Institute.
A 2016 review of animal studies indicated that cannabidiol has potential as an anxiolytic for relief of anxiety-related disorders and fear. Reviews of preliminary research showed cannabidiol has potential for improving addictive disorders and drug dependence, although as of 2016, they indicated limited high-quality evidence for anti-addictive effects in people.
Both in Canada and the US, the most critical problem to be addressed for commercial exploitation of C. sativa is the possible unauthorized drug use of the plant. Indeed, the reason hemp cultivation was made illegal in North America was concern that the hemp crop was a drug menace. The drug potential is, for practical purposes, measured by the presence of THC. THC is the world’s most popular illicit chemical, and indeed the fourth most popular recreational drug, after caffeine, alcohol, and nicotine. “Industrial hemp” is a phrase that has become common to designate hemp used for commercial non-intoxicant purposes. Small and Cronquist (1976) split C. sativa into two subspecies: C. sativa subsp. sativa, with less than 0.3% (dry weight) of THC in the upper (reproductive) part of the plant, and C. sativa subsp. indica (Lam.) E. Small & Cronq. with more than 0.3% THC. This classification has since been adopted in the European Community, Canada, and parts of Australia as a dividing line between cultivars that can be legally cultivated under license and forms that are considered to have too high a drug potential. For a period, 0.3% was also the allowable THC content limit for cultivation of hemp in the Soviet Union. In the US, Drug Enforcement Agency guidelines issued Dec. 7, 1999 expressly allowed products with a THC content of less than 0.3% to enter the US without a license; but subsequently permissible levels have been a source of continuing contention. Marijuana in the illicit market typically has a THC content of 5% to 10% (levels as high as 25% have been reported), and as a point of interest, a current Canadian government experimental medicinal marijuana production contract calls for the production of 6% marijuana. As noted above, a level of about 1% THC is considered the threshold for marijuana to have intoxicating potential, so the 0.3% level is conservative, and some countries (e.g. parts of Australia, Switzerland) have permitted the cultivation of cultivars with higher levels. It should be appreciated that there is considerable variation in THC content in different parts of the plant. THC content increases in the following order: achenes (excluding bracts), roots, large stems, smaller stems, older and larger leaves, younger and smaller leaves, flowers, perigonal bracts covering both the female flowers and fruits. It is well known in the illicit trade how to screen off the more potent fractions of the plant in order to increase THC levels in resultant drug products. Nevertheless, a level of 0.3% THC in the flowering parts of the plant is reflective of material that is too low in intoxicant potential to actually be used practically for illicit production of marijuana or other types of cannabis drugs. Below, the problem of permissible levels of THC in food products made from hempseed is discussed.
Germplasm for the improvement of hemp is vital for the future of the industry in North America. However, there are no publicly available germplasm banks housing C. sativa in North America. The hundreds of seed collections acquired for Small’s studies (reviewed in Small 1979) were destroyed in 1980 because Canadian government policy at that time envisioned no possibility that hemp would ever be developed as a legitimate crop. An inquiry regarding the 56 United States Department of Agriculture hemp germplasm collections supplied to and grown by Small and Beckstead (1973) resulted in the reply that there are no remaining hemp collections in USDA germplasm holdings, and indeed that were such to be found they would have to be destroyed. While hemp has been and still is cultivated in Asia and South America, it is basically in Europe that germplasm banks have made efforts to preserve hemp seeds. The Vavilov Institute of Plant Research in St. Petersburg, Russia has by far the largest germplasm collection of hemp of any public gene bank, with about 500 collections. Detailed information on the majority of hemp accessions of the Vavilov Institute can be found in Anon. (1975). Budgetary problems in Russia have endangered the survival of this invaluable collection, and every effort needs to be made to find new funding to preserve it. Maintenance and seed generation issues for the Vavilov hemp germplasm collection are discussed in a number of articles in the Journal of the International Hemp Association (Clarke 1998b; Lemeshev et al. 1993, 1994). The Gatersleben gene bank of Germany, the 2nd largest public gene bank in Europe, has a much smaller Cannabis collection, with less than 40 accessions (detailed information on the hemp accessions of the Gatersleben gene bank are available at fox-serv.ipk-gatersleben.de/). Because hemp is regaining its ancient status as an important crop, a number of private germplasm collections have been assembled for the breeding of cultivars as commercial ventures (de Meijer and van Soest 1992; de Meijer 1998), and of course these are available only on a restricted basis, if at all.
A rather thorough analysis of the scope of the illicit marijuana industry in Canada for 1998 is reported at www.rcmp-grc.gc.ca/html/drugsituation.htm#Marihuana and summarized in MacLeod (1999). At least 800 tonnes (t) of marijuana were grown in Canada in 1998, representing a harvest of 4.7 million flowering plants. More than 50% of the marijuana available in Canada is grown domestically. An average mature plant was estimated to produce 170 g of “marketable substance.” The value of the Canadian crop is uncertain, but has been estimated to be in the billions of dollars annually (Heading 1998; MacLeod 1999).
Despite advances in pharmacologic and nonpharmacologic management, nausea and vomiting (N/V) remain distressing side effects for cancer patients and their families. Dronabinol, a synthetically produced delta-9-THC, was approved in the United States in 1986 as an antiemetic to be used in cancer chemotherapy. Nabilone, a synthetic derivative of delta-9-THC, was first approved in Canada in 1982 and is now also available in the United States. Both dronabinol and nabilone have been approved by the U.S. Food and Drug Administration (FDA)for the treatment of N/V associated with cancer chemotherapy in patients who have failed to respond to conventional antiemetic therapy. Numerous clinical trials and meta-analyses have shown that dronabinol and nabilone are effective in the treatment of N/V induced by chemotherapy.[25-28] The National Comprehensive Cancer Network Guidelines recommend cannabinoids as breakthrough treatment for chemotherapy-related N/V. The American Society for Clinical Oncology (ASCO) antiemetic guidelines updated in 2017 recommends that the FDA-approved cannabinoids, dronabinol or nabilone, be used to treat N/V that is resistant to standard antiemetic therapies.
Hemp, (Cannabis sativa), also called industrial hemp, plant of the family Cannabaceae cultivated for its fibre (bast fibre) or its edible seeds. Hemp is sometimes confused with the cannabis plants that serve as sources of the drug marijuana and the drug preparation hashish. Although all three products—hemp, marijuana, and hashish—contain tetrahydrocannabinol (THC), a compound that produces psychoactive effects in humans, the variety of cannabis cultivated for hemp has only small amounts of THC relative to that grown for the production of marijuana or hashish.
In an in vivo model using severe combined immunodeficient mice, subcutaneous tumors were generated by inoculating the animals with cells from human non-small cell lung carcinoma cell lines. Tumor growth was inhibited by 60% in THC-treated mice compared with vehicle-treated control mice. Tumor specimens revealed that THC had antiangiogenic and antiproliferative effects. However, research with immunocompetent murine tumor models has demonstrated immunosuppression and enhanced tumor growth in mice treated with THC.[24,25]
Fig. 8. Scanning electron micrographs of the abaxial surface of a perigonal bract (which envelops the fruit). These bracts are the most intoxicating part of the plant, and may contain 20% THC, dry weight. The resin is synthesized both in stalked and sessile glands. Multicellular secretory glands (of phallic appearance), some broken stalks of these (note cellular appearance), and unicellular cystolith hairs (claw-like structures) are pictured. Fig. 9. Some important cannabinoids of cannabis resin. D9-THC (delta-9 tetrahydrocannabinol) is the chief intoxicant chemical and predominates in intoxicant strains, while the isomer D8-THC is usually present in no more than trace amounts. CBD (cannabidiol) is the chief non-intoxicant chemical, and predominates in non-intoxicant strains; it has sedative effects. The non-intoxicant CBN (cannabinol) is a frequent degradation or oxidation product. The non-intoxicant cannabichromene (CBC) is typically found in trace amounts in intoxicant strains. The non-intoxicant cannabigerol (CBG) is considered to be a precursor of the other cannbinoids (see Fig. 10).
In the early 1990s, industrial hemp agriculture in North America began with the Hemp Awareness Committee at the University of Manitoba. The Committee worked with the provincial government to get research and development assistance, and was able to obtain test plot permits from the Canadian government. Their efforts led to the legalization of industrial hemp (hemp with only minute amounts of tetrahydrocannabinol) in Canada and the first harvest in 1998.
CBD has also been demonstrated to exert a chemopreventive effect in a mouse model of colon cancer. In this experimental system, azoxymethane increased premalignant and malignant lesions in the mouse colon. Animals treated with azoxymethane and CBD concurrently were protected from developing premalignant and malignant lesions. In in vitro experiments involving colorectal cancer cell lines, the investigators found that CBD protected DNA from oxidative damage, increased endocannabinoid levels, and reduced cell proliferation. In a subsequent study, the investigators found that the antiproliferative effect of CBD was counteracted by selective CB1 but not CB2 receptor antagonists, suggesting an involvement of CB1 receptors.
Cannabis plants can be male, female, or hermaphrodite. The dried marijuana flowers that humans consume, however, come from the female plant. That’s because female plants produce large resin-secreting flowers that are rich in cannabinoids and free of seeds. Hence, female plants are the ones growers prefer, though of course, male marijuana plants are a requirement for pollination.
And without high-quality trials, experts don’t know how much is best for a given purpose. The staff at Roth’s dispensary told her, “Try some once or twice a day and see what happens.” (Half a dropper’s worth was a good amount for her.) One thing scientists feel confident about is that CBD is not dangerous. It won’t damage vital organs even at doses as high as 5,000 mg a day, Marcu says, and nobody has died from simply overdosing on a cannabis product.
Cannabinoids may also contribute to pain modulation through an anti-inflammatory mechanism; a CB2 effect with cannabinoids acting on mast cell receptors to attenuate the release of inflammatory agents, such as histamine and serotonin, and on keratinocytes to enhance the release of analgesic opioids has been described.[45-47] One study reported that the efficacy of synthetic CB1- and CB2-receptor agonists were comparable with the efficacy of morphine in a murine model of tumor pain.
Hemp, Canabis sativa is a plant originally from central Asia. It was cultivated with, and sometimes in place of flax because the stem fibers are similar. By the seventeenth century, Russia, Latvia, and other countries around the Baltic Sea were the major producers of hemp. It was from these areas Britain obtained its supply. However, during periods of military hostilities, the English had trouble acquiring enough hemp.
Cannabis sativa L. subsp. sativa var. sativa is the variety grown for industrial use, while C. sativa subsp. indica generally has poor fiber quality and female buds from this variety are primarily used for recreational and medicinal purposes. The major differences between the two types of plants are the appearance, and the amount of Δ9-tetrahydrocannabinol (THC) secreted in a resinous mixture by epidermal hairs called glandular trichomes, although they can also be distinguished genetically. Oilseed and fiber varieties of Cannabis approved for industrial hemp production produce only minute amounts of this psychoactive drug, not enough for any physical or psychological effects. Typically, hemp contains below 0.3% THC, while cultivars of Cannabis grown for medicinal or recreational use can contain anywhere from 2% to over 20%.
Individuals are responsible for sourcing their own propagative material. TNHIA is a great resource. All seed or plant material being brought into the state must have prior approval by the Tennessee Department of Agriculture (TDA). Please use our seed and propagule acquisition forms to request approval. If importing from another state use this link: https://www.tn.gov/content/dam/tn/agriculture/documents/planthealth/Domestic_Seed_Import_Requirements.pdf
Throughout his lifetime, George Washington cultivated hemp at Mount Vernon for industrial uses. The fibers from hemp held excellent properties for making rope and sail canvas. In addition, hemp fibers could be spun into thread for clothing or, as indicated in Mount Vernon records, used in repairing the large seine nets Washington used in his fishing operation along the Potomac.
“The plan? Whip the public into a frenzy over ill effects of marijuana, the psychoactive leaves and flowers of the hemp plant; the reputation of the fibers and seeds used by industry would be posing little threat to society emerged as the ‘assassin of youth.’ The strategy worked. In 1937, with virtually no warning, Congress announced a prohibitive tax on hemp, effectively ending the production and sale of the plant in the United States.
Hemp was made illegal to grow without a permit in the U.S. under the Controlled Substances Act passed in 1970 because of its relation to marijuana, and any imported hemp products must meet a zero tolerance level. Some states have made the cultivation of industrial hemp legal, but farmers in many states have not yet begun to grow it because of resistance from the federal Drug Enforcement Administration, making "large-scale hemp growing" in the United States "not viable" as late as 2013. In 2013, after the legalization of cannabis in the state, several farmers in Colorado planted and harvested several acres of hemp, bringing in the first hemp crop in the United States in over half a century. Colorado, Vermont, California, and North Dakota have passed laws enabling hemp licensure. All four states are waiting for permission to grow hemp from the DEA. Currently, Oregon has licensed industrial hemp as of August 2009. Congress included a provision in the Agricultural Act of 2014 that allowed colleges and state agencies to grow and conduct research on hemp in states where it is legal. Hemp production in Kentucky, formerly the United States' leading producer, resumed in 2014. Hemp production in North Carolina resumed in 2017, and in Washington State the same year. By the end of 2017, at least 34 U.S. states had industrial hemp programs. In 2018, New York began taking strides in industrial hemp production, along with hemp research pilot programs at Cornell University, Binghamton University and SUNY Morrisville.
In recent years, hemp has been growing in popularity as a material used in shoes. Today you can find boots, athletic shoes, sandals, and dress shoes that are made with 100% hemp fiber, or textiles that blend hemp fibers with materials such as cotton, jute, virgin polyester, and recycled polyester. The strength of hemp fibers makes it an ideal material for shoes because it's durable. In addition, it's breathable and naturally antimicrobial, so it doesn't hold on to odors. Because hemp can be grown sustainably, shoes, clothing, and accessories made with hemp are representative of the sustainable fashion movement.